Ann: Shareholder Update, page-222

I have found it odd that Biotron has not released the results of the Covid trial which surely must be known by them at this stage. I was thinking that a possible reason for this is that they were waiting for the more complex HIV trial results to come through first so they can release all results to the market at once. However this doesn’t sound right to me, if the Covid trial results were good/outstanding, you would expect them to immediately (rather than imminently) release the results to maximise exposure of Biotron to the market. Which leaves me now thinking that the Covid results were not as hoped for so they have decided to wait for the HIV result, hoping that these may be good and thus soften the blow to the market re the disappointing Covid results.